Cerus Endovascular, a neuroradiology technology developer spun-out of Oxford University, has secured £600k from the North West Fund for Biomedical (NWFB) as part of a larger £1.5m funding round to entice it to the north west of the UK.
Cerus, which is currently based in Oxford’s tech cluster, is planning a move to the Liverpool Science Park following the investment by NWFB. Part of the £155m North West Fund, financed by the European Regional Development Fund and the European Investment Bank, the initiative aims to attract business away from the ‘Golden Triangle’ of Oxford, Cambridge and London to the north west of England.
The funding will be used by Cerus to develop its intracranial aneurysm treatments and to fund extensive clinical trials.
J Todd Derbin, executive chairman of Cerus Endovascular, said: “We believe our device represents the next generation in the minimally invasive treatment of neurovascular diseases, particularly intracranial aneurysms. The investment means we can further develop our technology, which addresses unmet clinical needs in the interventional neuroradiology, cardiovascular, urology and gastroenterology markets.”
